Global Diabetes Treatment Market Research Report 2023

Report ID: 1985593 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetes Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Insulin
        1.2.3 Oral Hypoglycaemic Drugs
        1.2.4 Non-Insulin Injectable Drugs
    1.3 Market by Application
        1.3.1 Global Diabetes Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Personal Use
        1.3.4 Clinic
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Diabetes Treatment Market Perspective (2017-2028)
    2.2 Diabetes Treatment Growth Trends by Region
        2.2.1 Diabetes Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Diabetes Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Diabetes Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Diabetes Treatment Market Dynamics
        2.3.1 Diabetes Treatment Industry Trends
        2.3.2 Diabetes Treatment Market Drivers
        2.3.3 Diabetes Treatment Market Challenges
        2.3.4 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Diabetes Treatment Players by Revenue
        3.1.1 Global Top Diabetes Treatment Players by Revenue (2017-2022)
        3.1.2 Global Diabetes Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Diabetes Treatment Revenue
    3.4 Global Diabetes Treatment Market Concentration Ratio
        3.4.1 Global Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetes Treatment Revenue in 2021
    3.5 Diabetes Treatment Key Players Head office and Area Served
    3.6 Key Players Diabetes Treatment Product Solution and Service
    3.7 Date of Enter into Diabetes Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Treatment Breakdown Data by Type
    4.1 Global Diabetes Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Diabetes Treatment Forecasted Market Size by Type (2023-2028)
5 Diabetes Treatment Breakdown Data by Application
    5.1 Global Diabetes Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Diabetes Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Diabetes Treatment Market Size (2017-2028)
    6.2 North America Diabetes Treatment Market Size by Country (2017-2022)
    6.3 North America Diabetes Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Diabetes Treatment Market Size (2017-2028)
    7.2 Europe Diabetes Treatment Market Size by Country (2017-2022)
    7.3 Europe Diabetes Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Diabetes Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Diabetes Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Diabetes Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Diabetes Treatment Market Size (2017-2028)
    9.2 Latin America Diabetes Treatment Market Size by Country (2017-2022)
    9.3 Latin America Diabetes Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Diabetes Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Diabetes Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Diabetes Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Company Detail
        11.1.2 Novo Nordisk Business Overview
        11.1.3 Novo Nordisk Diabetes Treatment Introduction
        11.1.4 Novo Nordisk Revenue in Diabetes Treatment Business (2017-2022)
        11.1.5 Novo Nordisk Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Detail
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Diabetes Treatment Introduction
        11.2.4 AstraZeneca Revenue in Diabetes Treatment Business (2017-2022)
        11.2.5 AstraZeneca Recent Development
    11.3 Teva Pharmaceuticals
        11.3.1 Teva Pharmaceuticals Company Detail
        11.3.2 Teva Pharmaceuticals Business Overview
        11.3.3 Teva Pharmaceuticals Diabetes Treatment Introduction
        11.3.4 Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2017-2022)
        11.3.5 Teva Pharmaceuticals Recent Development
    11.4 Merck＆Company
        11.4.1 Merck＆Company Company Detail
        11.4.2 Merck＆Company Business Overview
        11.4.3 Merck＆Company Diabetes Treatment Introduction
        11.4.4 Merck＆Company Revenue in Diabetes Treatment Business (2017-2022)
        11.4.5 Merck＆Company Recent Development
    11.5 Medtronic
        11.5.1 Medtronic Company Detail
        11.5.2 Medtronic Business Overview
        11.5.3 Medtronic Diabetes Treatment Introduction
        11.5.4 Medtronic Revenue in Diabetes Treatment Business (2017-2022)
        11.5.5 Medtronic Recent Development
    11.6 Johnson＆Johnson
        11.6.1 Johnson＆Johnson Company Detail
        11.6.2 Johnson＆Johnson Business Overview
        11.6.3 Johnson＆Johnson Diabetes Treatment Introduction
        11.6.4 Johnson＆Johnson Revenue in Diabetes Treatment Business (2017-2022)
        11.6.5 Johnson＆Johnson Recent Development
    11.7 Sanofi
        11.7.1 Sanofi Company Detail
        11.7.2 Sanofi Business Overview
        11.7.3 Sanofi Diabetes Treatment Introduction
        11.7.4 Sanofi Revenue in Diabetes Treatment Business (2017-2022)
        11.7.5 Sanofi Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Detail
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline Diabetes Treatment Introduction
        11.8.4 GlaxoSmithKline Revenue in Diabetes Treatment Business (2017-2022)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Abbott Laboratories
        11.9.1 Abbott Laboratories Company Detail
        11.9.2 Abbott Laboratories Business Overview
        11.9.3 Abbott Laboratories Diabetes Treatment Introduction
        11.9.4 Abbott Laboratories Revenue in Diabetes Treatment Business (2017-2022)
        11.9.5 Abbott Laboratories Recent Development
    11.10 Benemae
        11.10.1 Benemae Company Detail
        11.10.2 Benemae Business Overview
        11.10.3 Benemae Diabetes Treatment Introduction
        11.10.4 Benemae Revenue in Diabetes Treatment Business (2017-2022)
        11.10.5 Benemae Recent Development
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Detail
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Diabetes Treatment Introduction
        11.11.4 Eli Lilly Revenue in Diabetes Treatment Business (2017-2022)
        11.11.5 Eli Lilly Recent Development
    11.12 Boehringer Ingelheim
        11.12.1 Boehringer Ingelheim Company Detail
        11.12.2 Boehringer Ingelheim Business Overview
        11.12.3 Boehringer Ingelheim Diabetes Treatment Introduction
        11.12.4 Boehringer Ingelheim Revenue in Diabetes Treatment Business (2017-2022)
        11.12.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Insulin
    Table 3. Key Players of Oral Hypoglycaemic Drugs
    Table 4. Key Players of Non-Insulin Injectable Drugs
    Table 5. Global Diabetes Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Diabetes Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Diabetes Treatment Market Share by Region (2017-2022)
    Table 9. Global Diabetes Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Diabetes Treatment Market Share by Region (2023-2028)
    Table 11. Diabetes Treatment Market Trends
    Table 12. Diabetes Treatment Market Drivers
    Table 13. Diabetes Treatment Market Challenges
    Table 14. Diabetes Treatment Market Restraints
    Table 15. Global Diabetes Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Diabetes Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Treatment as of 2021)
    Table 18. Ranking of Global Top Diabetes Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Diabetes Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Diabetes Treatment Product Solution and Service
    Table 22. Date of Enter into Diabetes Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Diabetes Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Diabetes Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Diabetes Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Diabetes Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Diabetes Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Diabetes Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Diabetes Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Diabetes Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Diabetes Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Diabetes Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Diabetes Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Diabetes Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Novo Nordisk Company Detail
    Table 43. Novo Nordisk Business Overview
    Table 44. Novo Nordisk Diabetes Treatment Product
    Table 45. Novo Nordisk Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 46. Novo Nordisk Recent Development
    Table 47. AstraZeneca Company Detail
    Table 48. AstraZeneca Business Overview
    Table 49. AstraZeneca Diabetes Treatment Product
    Table 50. AstraZeneca Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 51. AstraZeneca Recent Development
    Table 52. Teva Pharmaceuticals Company Detail
    Table 53. Teva Pharmaceuticals Business Overview
    Table 54. Teva Pharmaceuticals Diabetes Treatment Product
    Table 55. Teva Pharmaceuticals Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 56. Teva Pharmaceuticals Recent Development
    Table 57. Merck＆Company Company Detail
    Table 58. Merck＆Company Business Overview
    Table 59. Merck＆Company Diabetes Treatment Product
    Table 60. Merck＆Company Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 61. Merck＆Company Recent Development
    Table 62. Medtronic Company Detail
    Table 63. Medtronic Business Overview
    Table 64. Medtronic Diabetes Treatment Product
    Table 65. Medtronic Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 66. Medtronic Recent Development
    Table 67. Johnson＆Johnson Company Detail
    Table 68. Johnson＆Johnson Business Overview
    Table 69. Johnson＆Johnson Diabetes Treatment Product
    Table 70. Johnson＆Johnson Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 71. Johnson＆Johnson Recent Development
    Table 72. Sanofi Company Detail
    Table 73. Sanofi Business Overview
    Table 74. Sanofi Diabetes Treatment Product
    Table 75. Sanofi Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 76. Sanofi Recent Development
    Table 77. GlaxoSmithKline Company Detail
    Table 78. GlaxoSmithKline Business Overview
    Table 79. GlaxoSmithKline Diabetes Treatment Product
    Table 80. GlaxoSmithKline Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Abbott Laboratories Company Detail
    Table 83. Abbott Laboratories Business Overview
    Table 84. Abbott Laboratories Diabetes Treatment Product
    Table 85. Abbott Laboratories Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 86. Abbott Laboratories Recent Development
    Table 87. Benemae Company Detail
    Table 88. Benemae Business Overview
    Table 89. Benemae Diabetes Treatment Product
    Table 90. Benemae Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 91. Benemae Recent Development
    Table 92. Eli Lilly Company Detail
    Table 93. Eli Lilly Business Overview
    Table 94. Eli Lilly Diabetes TreatmentProduct
    Table 95. Eli Lilly Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 96. Eli Lilly Recent Development
    Table 97. Boehringer Ingelheim Company Detail
    Table 98. Boehringer Ingelheim Business Overview
    Table 99. Boehringer Ingelheim Diabetes TreatmentProduct
    Table 100. Boehringer Ingelheim Revenue in Diabetes Treatment Business (2017-2022) & (US$ Million)
    Table 101. Boehringer Ingelheim Recent Development
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetes Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Insulin Features
    Figure 3. Oral Hypoglycaemic Drugs Features
    Figure 4. Non-Insulin Injectable Drugs Features
    Figure 5. Global Diabetes Treatment Market Share by Application in 2021 & 2028
    Figure 6. Hospital Case Studies
    Figure 7. Personal Use Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Others Case Studies
    Figure 10. Diabetes Treatment Report Years Considered
    Figure 11. Global Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Diabetes Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Diabetes Treatment Market Share by Region: 2021 VS 2028
    Figure 14. Global Diabetes Treatment Market Share by Players in 2021
    Figure 15. Global Top Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Treatment as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Diabetes Treatment Revenue in 2021
    Figure 17. North America Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Diabetes Treatment Market Share by Country (2017-2028)
    Figure 19. United States Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Diabetes Treatment Market Share by Country (2017-2028)
    Figure 23. Germany Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Diabetes Treatment Market Share by Region (2017-2028)
    Figure 31. China Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Diabetes Treatment Market Share by Country (2017-2028)
    Figure 39. Mexico Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Diabetes Treatment Market Share by Country (2017-2028)
    Figure 43. Turkey Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Diabetes Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Novo Nordisk Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 46. AstraZeneca Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 47. Teva Pharmaceuticals Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 48. Merck＆Company Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 49. Medtronic Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 50. Johnson＆Johnson Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 51. Sanofi Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 52. GlaxoSmithKline Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 53. Abbott Laboratories Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 54. Benemae Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 55. Eli Lilly Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 56. Boehringer Ingelheim Revenue Growth Rate in Diabetes Treatment Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
AstraZeneca
Teva Pharmaceuticals
Merck＆Company
Medtronic
Johnson＆Johnson
Sanofi
GlaxoSmithKline
Abbott Laboratories
Benemae
Eli Lilly
Boehringer Ingelheim
Frequently Asked Questions
Diabetes Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diabetes Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diabetes Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports